Stephane Martin

Stephane Martin has a wide range of experience in quality assurance and management roles. Stephane started their career in 1998 at Lantheus Medical Imaging as a Laboratory Technologist and later became a Quality Assurance Specialist II. In 2016, they joined IsoLogic Innovative Radiopharmaceuticals as a QA Manager for the PET network and then transitioned to the role of Associate Director of Quality. In 2018, they took on the role of Interim Vice President of CMC and Quality.

Stephane Martin obtained a DEC in Médecine nucléaire from Collège Ahuntsic in 1997. Following that, they pursued a Bacc in Biochimie from Université de Sherbrooke, graduating in 2002. Stephane furthered their studies at the same university and received a Maitrise in Pharmacologie in 2006.